NZ Multiple Myeloma Research Review Issue 4

In this issue:

Frontline carfilzomib + lenalidomide and low-dose dexamethasone
Second malignancies with thalidomide and lenalidomide maintenance
Thrombosis decreases survival in MM
Curative virotherapy in murine myeloma
Bortezomib induction and maintenance
Gene sequencing reveals genomic initiating events, evolution and clonal tides
Diffuse MRI pattern associated with poor outcomes
Maintenance bortezomib + thalidomide or prednisone in elderly MM
Superiority of pretransplant VTD induction
Carfilzomib in relapsed/ refractory MM

Please login below to download this issue (PDF)

Subscribe